Cargando…

Metastatic carcinoma of unknown primary with complete metabolic response following sorafenib-based chemotherapy

BACKGROUND: The treatment of carcinoma of unknown primary based on histopathology and immunohistochemistry is generally chemotherapy. The use of molecular markers, genetic profiling platforms, and personalized medicine is under active investigation. CASE REPORT: We report the case of a 56-year-old p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Usón Junior, Pedro Luiz Serrano, Wagner, Jairo, Corpa, Marcus Vinicius de Nigro, Coelho, Iracema Moraes, Nagourney, Robert A, Yamaguchi, Nise Hitomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429643/ https://www.ncbi.nlm.nih.gov/pubmed/30915220 http://dx.doi.org/10.1177/2050313X19838739

Ejemplares similares

Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib
por: Botrus, Gehan, et al.
Publicado: (2022)

Stabilization of metastatic myxopapillary ependymoma with sorafenib
por: Fegerl, Gundula, et al.
Publicado: (2012)

Immunotherapy in biliary tract cancers: Current evidence and future perspectives
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2022)

Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2023)

Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer
por: Janjigian, Yelena Y., et al.
Publicado: (2015)

Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer
por: Ferrario, Cristiano, et al.
Publicado: (2016)

Clinical Benefit of Sorafenib Combined with Paclitaxel and Carboplatin to a Patient with Metastatic Chemotherapy‐Refractory Testicular Tumors
por: Lian, Bijun, et al.
Publicado: (2019)

Systematic review and meta-analysis of docetaxel perioperative chemotherapy regimens in gastric and esophagogastric tumors
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2019)

Sorafenib for treating head and neck adenocarcinoma of unknown primary site: a case report
por: Chen, Jingxian, et al.
Publicado: (2020)

Sorafenib in the management of metastatic renal cell carcinoma
por: Guevremont, C., et al.
Publicado: (2009)

Metastatic Melanoma with an Unknown Primary
por: Babu, Anuradha Kakkanatt, et al.
Publicado: (2022)

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial
por: Procopio, G, et al.
Publicado: (2011)

Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
por: Schlemmer, Marcus, et al.
Publicado: (2019)

WHO, RECIST, and immune-related response criteria: is it time to revisit pembrolizumab results?
por: Ades, Felipe, et al.
Publicado: (2015)

“Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”?
por: Kolling, Stefan, et al.
Publicado: (2020)

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma
por: Zhao, Yang, et al.
Publicado: (2019)

A New Approach to the Treatment of Metastatic Paraganglioma: Sorafenib
por: Gunaldi, Meral, et al.
Publicado: (2014)

The known knowns, known unknowns, and unknown unknowns of surveys and sleep
por: Shaker, Marcus, et al.
Publicado: (2022)

Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma
por: Ikeda, Atsuyuki, et al.
Publicado: (2021)

Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma
por: Ito, Yasuhiro, et al.
Publicado: (2017)

Precision Medicine Targeting FGFR2 Genomic Alterations in Advanced Cholangiocarcinoma: Current State and Future Perspectives
por: Zugman, Miguel, et al.
Publicado: (2022)

Sorafenib in metastatic MTC – a case report and minireview of the literature
por: Petrova, Mila, et al.
Publicado: (2010)

The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies
por: Usón, Pedro Luiz Serrano, et al.
Publicado: (2020)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2017)

Metastatic Meningioma Presenting as Cancer of Unknown Primary
por: Gupta, Vinay, et al.
Publicado: (2013)

Metabolic phenotypes in primary unknown metastatic carcinoma
por: Kim, Hye Min, et al.
Publicado: (2014)

Right Atrial Metastatic Melanoma with Unknown Primaries
por: Kuriakose, Robin, et al.
Publicado: (2015)

Metastatic tumor of the hand of unknown primary origin
por: Giordano, Vincenzo, et al.
Publicado: (2019)

Metastatic melanoma of unknown origin mimicking neurofibromatosis
por: Chen, Lauren, et al.
Publicado: (2020)

Combined Immunotherapy in Metastatic Melanoma with Unknown Primary
por: Khan, Yasir, et al.
Publicado: (2019)

Recent advances in understanding cholangiocarcinoma
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2020)

Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
por: Ikeda, M., et al.
Publicado: (2016)

A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates
por: Ott, Patrick A., et al.
Publicado: (2010)

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
por: McFarland, Daniel C, et al.
Publicado: (2014)

The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance
por: Chow, Ariel Ka-Man, et al.
Publicado: (2013)

Sorafenib Improves Survival in Metastatic Hepatocellular Carcinoma: A Case Report
por: Nery, Filipe, et al.
Publicado: (2010)

Exacerbation of Psoriasis with Pustulation by Sorafenib in a Patient with Metastatic Hepatocellular Carcinoma
por: Ohashi, Takenobu, et al.
Publicado: (2019)

Outstanding Response to Sorafenib in a Patient with Metastatic Gastrointestinal Stromal Tumour
por: Brinch, Charlotte, et al.
Publicado: (2021)

Efficacy of oral metformin in a patient with metastatic adrenocortical carcinoma: Examination of mechanisms and therapeutic implications
por: Peixoto, RD, et al.
Publicado: (2018)

SUN-919 Ectopic ACTH Syndrome: An Aggressive Presentation Due to Metastatic Liver Cancer of Unknown Primary
por: Serrano, Ivan Alexander, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r4i3ra8h0755e3tqa8kb80f6kb